Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants - PubMed (original) (raw)
. 2010 Apr 8;115(14):2835-44.
doi: 10.1182/blood-2009-07-233049. Epub 2009 Dec 23.
Affiliations
- PMID: 20032505
- DOI: 10.1182/blood-2009-07-233049
Free article
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants
Ronald W Stam et al. Blood. 2010.
Free article
Abstract
Acute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by a poor prognosis and a high incidence of MLL translocations. Several studies demonstrated the unique gene expression profile associated with MLL-rearranged ALL, but generally small cohorts were analyzed as uniform patient groups regardless of the type of MLL translocation, whereas the analysis of translocation-negative infant ALL remained unacknowledged. Here we generated and analyzed primary infant ALL expression profiles (n = 73) typified by translocations t(4;11), t(11;19), and t(9;11), or the absence of MLL translocations. Our data show that MLL germline infant ALL specifies a gene expression pattern that is different from both MLL-rearranged infant ALL and pediatric precursor B-ALL. Moreover, we demonstrate that, apart from a fundamental signature shared by all MLL-rearranged infant ALL samples, each type of MLL translocation is associated with a translocation-specific gene expression signature. Finally, we show the existence of 2 distinct subgroups among t(4;11)-positive infant ALL cases characterized by the absence or presence of HOXA expression, and that patients lacking HOXA expression are at extreme high risk of disease relapse. These gene expression profiles should provide important novel insights in the complex biology of MLL-rearranged infant ALL and boost our progress in finding novel therapeutic solutions.
Similar articles
- Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Stumpel DJ, Schneider P, van Roon EH, Boer JM, de Lorenzo P, Valsecchi MG, de Menezes RX, Pieters R, Stam RW. Stumpel DJ, et al. Blood. 2009 Dec 24;114(27):5490-8. doi: 10.1182/blood-2009-06-227660. Epub 2009 Oct 23. Blood. 2009. PMID: 19855078 - Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin Siblings.
Urtishak KA, Robinson BW, Rappaport EF, Sarezky MD, Biegel JA, Nichols KE, Wilmoth DM, Wang LS, Stern JW, Felix CA. Urtishak KA, et al. Pediatr Blood Cancer. 2016 Jul;63(7):1175-80. doi: 10.1002/pbc.25957. Epub 2016 Mar 21. Pediatr Blood Cancer. 2016. PMID: 26999444 - MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
Juszczynski P, Rodig SJ, Ouyang J, O'Donnell E, Takeyama K, Mlynarski W, Mycko K, Szczepanski T, Gaworczyk A, Krivtsov A, Faber J, Sinha AU, Rabinovich GA, Armstrong SA, Kutok JL, Shipp MA. Juszczynski P, et al. Clin Cancer Res. 2010 Apr 1;16(7):2122-30. doi: 10.1158/1078-0432.CCR-09-2765. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332322 Free PMC article. - Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menéndez P. Sanjuan-Pla A, et al. Blood. 2015 Dec 17;126(25):2676-85. doi: 10.1182/blood-2015-09-667378. Epub 2015 Oct 13. Blood. 2015. PMID: 26463423 Free PMC article. Review. - Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T, Brady HJ. Chowdhury T, et al. Blood Cells Mol Dis. 2008 Mar-Apr;40(2):192-9. doi: 10.1016/j.bcmd.2007.07.005. Epub 2007 Oct 1. Blood Cells Mol Dis. 2008. PMID: 17905612 Review.
Cited by
- LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.
Gracia-Maldonado G, Clark J, Burwinkel M, Greenslade B, Wunderlich M, Salomonis N, Leone D, Gatti E, Pierre P, Kumar AR, Lee LH. Gracia-Maldonado G, et al. Haematologica. 2022 Apr 1;107(4):803-815. doi: 10.3324/haematol.2020.257451. Haematologica. 2022. PMID: 33910331 Free PMC article. - HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.
Symeonidou V, Ottersbach K. Symeonidou V, et al. Exp Hematol. 2021 Jan;93:38-43.e5. doi: 10.1016/j.exphem.2020.10.002. Epub 2020 Oct 15. Exp Hematol. 2021. PMID: 33069783 Free PMC article. - Epigenetic Effects of Benzene in Hematologic Neoplasms: The Altered Gene Expression.
Spatari G, Allegra A, Carrieri M, Pioggia G, Gangemi S. Spatari G, et al. Cancers (Basel). 2021 May 14;13(10):2392. doi: 10.3390/cancers13102392. Cancers (Basel). 2021. PMID: 34069279 Free PMC article. Review. - High-Throughput Drug Library Screening in Primary _KMT2A_-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling.
Wander P, Arentsen-Peters STCJM, Vrenken KS, Pinhanҫos SM, Koopmans B, Dolman MEM, Jones L, Garrido Castro P, Schneider P, Kerstjens M, Molenaar JJ, Pieters R, Zwaan CM, Stam RW. Wander P, et al. Biomedicines. 2022 Mar 10;10(3):638. doi: 10.3390/biomedicines10030638. Biomedicines. 2022. PMID: 35327440 Free PMC article. - Cholesterol esters as growth regulators of lymphocytic leukaemia cells.
Mulas MF, Abete C, Pulisci D, Pani A, Massidda B, Dessì S, Mandas A. Mulas MF, et al. Cell Prolif. 2011 Aug;44(4):360-71. doi: 10.1111/j.1365-2184.2011.00758.x. Epub 2011 Jun 6. Cell Prolif. 2011. PMID: 21645151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases